Ralph Lauren (RL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Individ ...

Hennes & Mauritz AB (HNNMY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Indi ...

Skyward Specialty Insurance (SKWD) closed the last trading session at $48.62, gaining 4.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $63.2 indicates a 30% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $9.08. While the lowest estimate of $49.00 indicates a 0.8% increase from the current price level, the most optimistic an ...

Elutia Inc. (ELUT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a chang ...

Core Viewpoint - Daktronics (DAKT) has shown a 6.3% increase in stock price over the past four weeks, with a mean price target of $25.33 indicating a potential upside of 29.2% from the current price of $19.61 [1] Price Targets and Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $8.33, where the lowest estimate is $16.00 (indicating an 18.4% decline) and the highest is $32.00 (indicating a 63.2% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Analyst Sentiment and Earnings Estimates - Analysts are optimistic about DAKT's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a 4.6% increase in the Zacks Consensus Estimate for the current year [11][12] - DAKT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' price targets can often be overly optimistic due to business incentives [3][8] - While price targets should not be ignored, they should be approached with skepticism, as they may not accurately predict stock price movements [10]

Fulcrum Therapeutics, Inc. (FULC) closed the last trading session at $11.99, gaining 21.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $19 indicates a 58.5% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $6.89. While the lowest estimate of $7.00 indicates a 41.6% decline from the current price level, the most optimistic a ...

Core Insights - Zacks Premium offers various tools for investors, including daily updates on stock rankings and industry performance, aimed at long-term investment success [1][2] Focus List Overview - The Zacks Focus List is a curated portfolio of 50 stocks designed for long-term investors, expected to outperform the market over the next 12 months [3] - Each stock in the Focus List is supported by a full Zacks Analyst Report, detailing the rationale behind its selection [4] Performance Metrics - In 2020, the Focus List achieved an annualized gain of 13.85%, outperforming the S&P 500's return of 9.38% - Cumulatively, from February 1, 1996, to March 31, 2021, the Focus List returned 2,519.23%, while the S&P 500 returned 854.95% [5] Methodology - The selection process for the Focus List relies on earnings estimate revisions, which are influenced by brokerage analysts who assess various factors affecting future earnings [6] - Positive changes in earnings estimates are likely to lead to further upward revisions, indicating potential for stock price increases [7] Zacks Rank System - The Zacks Rank is a proprietary model that uses changes in quarterly earnings expectations to guide investors in building a successful portfolio [8] - Stocks are classified into five groups based on four main factors: Agreement, Magnitude, Upside, and Surprise, with the Focus List primarily featuring 1 (Strong Buy) and 2 (Buy) ranked stocks [9] Stock Price Dynamics - Stocks with rising earnings estimates tend to experience price momentum, making Focus List stocks attractive for investment [10][11] Company Spotlight: GE HealthCare Technologies - GE HealthCare Technologies operates in four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, focusing on integrated solutions in medtech [12] - Since its addition to the Focus List on January 4, 2023, GEHC shares have increased by 37.46%, from $60.49 to $83.15, and currently holds a 3 (Hold) rating on the Zacks Rank [13]

Commercial Metals (CMC) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this manufacturer and recycler of steel and metal products, should get reflected in its stock price. After all, empirical re ...

Investors might want to bet on Beyond Meat (BYND) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual i ...

Planet Fitness (PLNT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing ear ...